Kostia Janssens
Corporate Officer/Principal at Epitopoietic Research Corp.
Kostia Janssens active positions
| Companies | Position | Start | End |
|---|---|---|---|
Epitopoietic Research Corp.
 Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Corporate Officer/Principal | - | - |
Career history of Kostia Janssens
Statistics
International
| United States | 2 |
Operational
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Epitopoietic Research Corp.
Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Kostia Janssens
- Experience
